Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XLA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $24,294
Award facts
- Contract value 100% obligated
- $24,293.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by June 18, 2025, and represents performance of work at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The IDC, awarded under the SPE2DB program, enables the agency to procure a comprehensive range of pharmaceutical products supporting medical supply requirements across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription medications, biologics, and medical consumables to military health systems. The contractor's extensive portfolio of prior awards demonstrates proven capability in delivering specialized pharmaceutical products ranging from oncology treatments to vaccines and injectable medications.
Quick answers
Who was awarded contract SPE2DX25F6XLA?
SPE2DX25F6XLA was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 17, 2025.
How much is contract SPE2DX25F6XLA worth?
The government has obligated $24,294 on SPE2DX25F6XLA.
Is contract SPE2DX25F6XLA an order under another contract?
Yes. SPE2DX25F6XLA is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XLA competed?
The extent of competition for SPE2DX25F6XLA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award